Thirty-Day Readmission Rate 2.8 Percent After Hysterectomy

Share this content:
Thirty-Day Readmission Rate 2.8 Percent After Hysterectomy
Thirty-Day Readmission Rate 2.8 Percent After Hysterectomy

THURSDAY, Sept. 15, 2016 (HealthDay News) -- For patients undergoing hysterectomy for benign indications, the 30-day readmission rate is 2.8 percent, with most readmissions occurring within 15 days, according to a study published in the October issue of Obstetrics & Gynecology.

Courtney A. Penn., M.D., from the University of Michigan Health System in Ann Arbor, and colleagues performed a retrospective analysis to examine patterns of 30-day readmission after hysterectomy for benign indications, including all surgical approaches (abdominal, laparoscopic, and vaginal).

The researchers found that the 30-day readmission rate was 2.8 percent, and readmissions were seen for 3.7, 2.6, and 2.1 percent of abdominal, laparoscopic, and vaginal hysterectomies, respectively. Compared with a vaginal approach, readmissions were more likely when hysterectomy was performed abdominally (adjusted odds ratio, 1.45; 95 percent confidence interval, 1.2 to 1.76) but not laparoscopically (adjusted odds ratio, 1.1; 95 percent confidence interval, 0.9 to 1.4). Most readmissions (82 percent) occurred within 15 days of discharge. The shortest and longest median times to readmission (three and 10 days) were associated with pain and noninfectious wound complications, respectively. The most common diagnosis was surgical site infection (36.6, 28.3, and 32.6 percent of abdominal, laparoscopic, and vaginal hysterectomies, respectively); surgical site infections, surgical injuries, and wound complications accounted for about half of all readmissions (51.5, 51.9, and 50.8 percent, respectively).

"Readmission reduction efforts should focus on early postdischarge follow-up, preventing infectious complications, and determining preventability of surgical-related reasons for readmission," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »